Gregory T. Hradsky Cyclacel Pharmaceuticals, Inc. (CYCC) insider trading activity
Gregory T. Hradsky is Director of Cyclacel Pharmaceuticals, Inc.. Currently has a direct ownership of 2,374 shares of CYCC, which is worth approximately $1,495. The most recent transaction as insider was on Jun 15, 2021, when has been sold 2,374 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
2.37K
0%
3M change
0%
12M change
Total Value Held
$1,495
GTH
Gregory T. Hradsky
Director
Berkeley Heights, NJ